Systematic Review of the Economic Evaluation of Sodium-Glucose Cotransporter-2 Inhibitors Used as Treatment in Patients with Heart Failure.

Kyungae Nam, Daniel Sung-Ho Cho, Hyunji Kim, Byungjin Kwon, Yebin Yoon,Chanhyun Park,Eui-Soon Kim,Jong-Chan Youn,Sun-Kyeong Park

Clinical drug investigation（2023）

引用 0|浏览0

暂无评分

摘要

Most of the studies reported the cost-effectiveness of dapagliflozin and empagliflozin in patients with HFrEF. However, the cost-effectiveness of empagliflozin differed from country to country regarding patients with HFpEF. We suggest that further economic evaluation of SGLT2 inhibitors should focus on patients with HFpEF in more countries.

查看译文

关键词

heart failure,inhibitors,sodium–glucose

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要